These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32198935)

  • 1. Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia.
    Geers LM; Pozhidaev IV; Ivanova SA; Freidin MB; Schmidt AF; Cohen D; Boiko AS; Paderina DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Kosterink JGW; Touw DJ; Loonen AJM
    Br J Clin Pharmacol; 2020 Sep; 86(9):1827-1835. PubMed ID: 32198935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
    Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
    BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
    Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
    BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.
    Ivanova SA; Osmanova DZ; Freidin MB; Fedorenko OY; Boiko AS; Pozhidaev IV; Semke AV; Bokhan NA; Agarkov AA; Wilffert B; Loonen AJ
    World J Biol Psychiatry; 2017 Apr; 18(3):239-246. PubMed ID: 27654063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA; Ellingrod VL; Acion L; Miller DD; Moline J; Tansey MJ; Schlechte JA
    Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ABCB1 Gene Polymorphisms with Efficacy and Adverse Reaction to Risperidone or Paliperidone in Han Chinese Schizophrenic Patients.
    Mi W; Liu F; Liu Y; Du B; Xiao W; Li L; Huang L; Lu T; He J; Shi L; Yue W; Zhang H
    Neurosci Bull; 2016 Dec; 32(6):547-549. PubMed ID: 27456824
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
    Hummer M; Huber J
    Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the association between antipsychotic use and hyperprolactinaemia.
    Bushe C; Shaw M; Peveler RC
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):46-55. PubMed ID: 18477620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin awareness: an essential consideration for physical health in schizophrenia.
    Montejo AL
    Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 gene polymorphisms and response to acute risperidone treatment.
    Kastelic M; Koprivsek J; Plesnicar BK; Serretti A; Mandelli L; Locatelli I; Grabnar I; Dolzan V
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):387-92. PubMed ID: 20060871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
    dos Santos Júnior A; Henriques TB; de Mello MP; Ferreira Neto AP; Paes LA; Della Torre OH; Sewaybricker LE; Fontana TS; Celeri EH; Guerra Júnior G; Dalgalarrondo P
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):738-48. PubMed ID: 26682995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
    Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
    J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients.
    Petrić D; Rački V; Gačo N; Kaštelan A; Graovac M
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):197-204. PubMed ID: 30758986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
    Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H
    Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.